New therapies in small cell lung cancer: A narrative review
Lung cancer overall is the second most common malignancy in both men and women in the United States and remains the leading cause of cancer death. Small cell lung cancer (SCLC) accounts for approximately 10–15% of all cases. Chemotherapy with a platinum agent and etoposide remains the standard of ca...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Publishing
2024-03-01
|
| Series: | Pneumon |
| Subjects: | |
| Online Access: | https://www.pneumon.org/New-therapies-in-small-cell-lung-cancer-A-narrative-nreview,183168,0,2.html |